Regeneron Pharmaceuticals (0R2M.LSE) Q3 2013 Earnings

6AugConfirmed
Q1 1
Q3 2013
0.79
2.27
3.75
5.23

Details

Expected EPS
N/A
Actual EPS
0.79
Surprise EPS
0.79
Surprise Percent
+∞%

Description

Regeneron Pharmaceuticals (0R2M.LSE) has reported earnings of 0.79 per share for Q3 2013.

0 Comments

Share your thoughts